With regulators embracing next-generation sequencing, how will the ICH Q5A(R2) guidelines reshape viral safety strategies for gene and cell therapies?
Sandra Zucchet, MSc
Advertisement
Articles by Sandra Zucchet, MSc
Advertisement
Latest Updated Articles
Viral Clearance & Viral Safety: Industry Trends & Key EventsPublished: May 9th 2025 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Charles River Incubator Cohort to Accelerate CGT Development
2
GSK and Oxford BioTherapeutics Drive Antibody-Based Cancer Drug Discovery at Industry Scale
3
BioPharma By The Numbers: Batch Failures in Biopharma Manufacturing
4
FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways
5
